Hold CL; maintain current sizing with no mechanical overlay, wait for $86-$87 flush or $91.43 reclaim triggers
Hold CL with no mechanical overlay. The stock continues leaking alpha against SPY, and neither covered-call overlays (failed 8/18: -0.9% alpha) nor trims-to-Underweight (alpha ceiling ~0% per 8/12) have produced positive alpha in CL across six consecutive decisions. Structural franchise quality (Hill's recovery, deleveraging, intact uptrend above 200 SMA, 2.32% yield with 2.5x FCF coverage, 63-year dividend record, 0.33 beta) is genuine and does not warrant trimming core exposure. Input cost lag from Hormuz oil shock will pressure Q3/Q4 prints; 22x forward PE on mid-single-digit grower with PEG 1.77 is fair not cheap. Patience is warranted with defined entry triggers; Q3 2026 earnings print is the forcing event for sizing reassessment.
| Position | Action |
|---|---|
| Current positioning | Maintain existing CL exposure at current sizing; do not add fresh capital at $90.87 |
| Confirmed close <$86.00 on volume >4M | Trigger trim position |
| Price at $86-$87 with confirmed hold and MACD stabilization | Re-engage/add to position |
| Clean reclaim of $91.43 (50 SMA) with MACD positive crossover | Re-engage/add to position |
CL's recent technical break below the 50 SMA represents an orderly pullback within an intact secular uptrend, not a breakdown — supported by expanding gross margins, four consecutive quarters of margin improvement, $3.46B in annual FCF generating a 75% capital return ratio while deleveraging, and a forward PE of 22x that is distorted by a one-time Q4'25 charge.
| Indicator | Value | Signal |
|---|---|---|
| close | $90.87 | bearish |
| 10_ema | $91.73 | bearish |
| 50_sma | $91.43 | bearish |
| 200_sma | $86.09 | bullish |
| rsi | 46.56 | neutral |
| macd | +0.02 | bearish |
| macdh | -0.25 | bearish |
| boll_middle | $91.95 | neutral |
| boll_ub | $94.24 | neutral |
| boll_lb | $89.67 | neutral |
| atr | $2.15 | neutral |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Clean reclaim of $91.43 (50 SMA) with MACD positive crossover
Then: Re-engage and add to position
Gross margins have expanded +210bps over four straight quarters, from 59.4% in Q3'25 to 61.5% in Q2'26, despite oil being up 36%. CL's pricing power and premium mix (EltaMD, Hill's Science Diet) have more than offset input cost pressures, proving the margin crush thesis wrong. Revenue grew +4.9% in Q2 even with US softness.
↩ rebuts: “Oil shock kills margins”
· concedes: If the Hormuz shock persists, Q3/Q4 margins will face pressure from input costs; The US consumer is fatigued with gasoline up and credit tight — CL itself flagged US softness in Q2; A PEG of 1.77 looks rich in isolation, though it ignores the quality premium CL commands
CL is a fully-priced defensive name with rising macro risk, deteriorating momentum, and a margin trajectory that's about to run into a wall.
· concedes: The 63-year dividend growth record is real; FCF of $3.46B and 75% capital return ratio math is correct; 200 SMA at $86 is technically the 'primary trend' support level; Q2'26 revenue growth of +4.9% was solid despite US weakness; Hormuz closure could de-escalate, removing the energy headwind thesis
→ vs neutral: Waiting for Q3 confirmation before buying a name with 63-year track record of compounding through every macro shock is timing the market, not investing
→ vs neutral: Trailing P/E appears rich only due to one-time Q4 2025 charge that is already in rearview; forward P/E of 22x is the correct lens
→ vs conservative: Oil shock bear case overstated—CL already expanded margins 150bps YoY despite 36% oil spike, demonstrating cost pass-through capability
→ vs neutral: MACD histogram printing -0.25 for four sessions is not fundamental deterioration; waiting for technical confirmation on a 0.33 beta name is 'trying to time which second of the hour to buy a savings bond'
Support: 90.21 · 89.67 · 86.09 | Resistance: 94.24 · 92.52 · 91.95 · 91.43
CL is in a short-term pullback within a structurally intact long-term uptrend (200 SMA rising at $86.09, price +5.6% above it). The 50 SMA at $91.43 is the critical pivot — price closed below it for the first time since early June. Momentum has rolled with MACD histogram negative for 4 straight sessions, but RSI at 46.56 is neutral and ATR is contracting ($2.15 from $2.55), indicating an orderly, non-panic selloff. Volatility is moderate (Bollinger bandwidth $4.57). Key scenarios: (1) BULLISH — close above $91.95 with rising MACD histogram targets $94.24; (2) NEUTRAL — churn between $89.67–$92.50; (3) BEARISH — daily close below $89.67 opens downside to $86.09 (200 SMA). ATR-based stops: 1× ATR = $88.72, 1.5× ATR = $87.65.
Market Cap
$72.44 B
Price / Trailing PE
35.78
Price / Forward PE
22.12
PEG Ratio
1.77
Price / Book
306.99
Dividend Yield
2.32%
EPS (TTM)
$2.54
Forward EPS
$4.11
Beta
0.327
52-Week Range
$74.55 – $99.33
Revenue (Q2'26)
$5,361 M
Gross Profit (Q2'26)
$3,296 M
Operating Income (Q2'26)
$1,016 M
Net Income (Q2'26)
$693 M
Diluted EPS (Q2'26)
$0.86
Gross Margin %
61.5%
Operating Margin %
19.0%
Net Margin %
9.7%
ROA
15.8%
ROE
267%
Total Debt
$7.86 B
Net Debt
$6.49 B
Stockholders' Equity
$0.24 B
Treasury Stock
$28.93 B
Current Ratio
1.03
Cash & Equivalents (Q2'26)
$1.37 B
Free Cash Flow (TTM)
$3.46 B
Free Cash Flow (Q2'26)
$867 M
CapEx (Q2'26)
$128 M
Dividends Paid (Q2'26)
$462 M
Buybacks (Q2'26)
$291 M
Revenue YoY Growth
+5%
Strengths
Concerns
HOLD — Colgate-Palmolive is a high-quality, defensive consumer staples franchise with strong cash generation, expanding margins (gross margin up to 61.5%), and disciplined capital return. The trailing PE of 35.8x appears elevated only because Q4'2025 was distorted by a one-time $866M charge; on forward earnings of $4.11, the stock trades at fair value (~22x). The 2.32% yield, very low beta (0.33), active deleveraging (debt down $900M YoY to $7.86B), and ~$3.46B TTM FCF make CL a strong holding for income/quality mandates. However, the slow-growth profile and modest near-term upside argue against aggressive new buying at current levels; add on pullbacks toward the $85-87 area (200-DMA) for better risk/reward.
Macro: Acute energy supply shock from Strait of Hormuz closure (oil +36% to ~$92/barrel) layered on sticky-inflation/higher-for-longer Fed regime (85% probability of no cuts in 2026 per Polymarket, $7.3M volume); US recession odds at 8% (down 0.5pp); Japan recession at 31%; US military escalation with Trump threatening Oman, USS George Washington redeploying; Iran conflict large enough to impact UK defense budget £11B; dollar dropping, risk assets bifurcating with US equities higher on Treasury buyback news but Asian tech lagging; US consumer showing fatigue at margin.